Sales of cannabinoid-containing products continue to rise. In 2020 it became a billion-dollar industry. With the increased use and popularity of CBD products, every clinician needs to critically appraise the evidence to determine if CBD should play a role in pain management and help educate patients about the potential risks.
Guest Author: Alex R. Mills, PharmD, BCACP, AAHIVP
Music by Good Talk
Mind Over Migraine: Can Mindfulness Improve Outcomes?
Is Home Blood Pressure Monitoring a “Home Run” for Blood Pressure Management?
Increasing the Patient-Clinician Connection: the “Presence 5 Practices”
FAST Take: Update on Febuxostat Cardiovascular Safety
Metformin During Pregnancy: Are the Results MiTy Enough to Change Practice?
Can a Polypill ‘TIP’ the Scale to a One-Size-Fits All Approach?
There’s an App for That! Can Smartphone Apps Assist with Smoking Cessation?
DECLARE-ing Another Victory for Dapagliflozin
Closing the Loop for Children with Type 1 Diabetes
Is it Time to Add Colchicine to the CVD Cocktail?
Canagliflozin Comeback? New Data on the Risk of Amputation
Using shared decision-making tools: Are they worth it?
Less Might Be Better: Deprescribing Antihypertensive Medications in Older Adults
I Screen, You Screen, We Should All Screen for Unhealthy Drug Use
Implementing Comprehensive Medication Management – Ingredients for Success
Can VOYAGER Put PAD Patients Back on Their Feet?
Will Bempedoic Acid provide SERENITY for Patients with Statin Intolerance?
No Provider Status, No Problem: CCM as a Revenue Source in Community Pharmacy
Powerful Placebos and Notorious Nocebos: Implications for Ambulatory Care
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive